7.28
7.28 (0%)
As of Feb 14, 2025
Ocular Therapeutix, Inc [OCUL]
Source:
Company Overview
Ocular Therapeutix, Inc is a biopharmaceutical company committed to redefining the retina experience. AXPAXLI (axitinib intravitreal hydrogel, also known as OTX-TKI), our product candidate for retinal disease, is based on our proprietary ELUTYX bioresorbable hydrogel-based formulation technology.
Country | United States |
Headquarters | bedford, massachusetts |
Phone Number | (781) 357-4000 |
Industry | manufacturing |
CEO | Antony Mattessich |
Website | www.ocutx.com |